RNF8 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 7.7715611723761E-15 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.65370003538612E-09 |
Normal-vs-Stage2 |
9.030400E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.259600E-03 |
Stage1-vs-Stage2 |
9.996600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.662200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.747600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.07576186742153E-12 |
Normal-vs-AfricanAmerican |
1.033590E-01 |
Normal-vs-Asian |
4.732100E-02 |
Caucasian-vs-AfricanAmerican |
5.694200E-01 |
Caucasian-vs-Asian |
8.543200E-01 |
AfricanAmerican-vs-Asian |
6.751600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.97200000004749E-06 |
Normal-vs-Female |
1.09430020600598E-10 |
Male-vs-Female |
9.611600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.102700E-03 |
Normal-vs-Extreme_Weight |
9.41809999988052E-08 |
Normal-vs-Obese |
4.581900E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.770000E-01 |
Normal_Weight-vs-Obese |
4.002200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.665600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.194400E-01 |
Normal-vs-Age(41-60Yrs) |
2.42739999999353E-05 |
Normal-vs-Age(61-80Yrs) |
1.88640003617735E-09 |
Normal-vs-Age(81-100Yrs) |
4.645800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.568600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.942400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.698600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.539400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.279600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.766000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.609400E-01 |
Normal-vs-Grade 3 |
9.188600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
4.091000E-01 |
Grade 2-vs-Grade 4 |
9.609400E-01 |
Grade 3-vs-Grade 4 |
9.188600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.1422978642488E-11 |
Normal-vs-N1 |
5.000000E-03 |
N0-vs-N1 |
4.828600E-01 |
|
|